Prospective Multiregional Evaluation of Protocol-Based Penicillin Allergy Delabeling in China: Real-World Outcomes Challenge Mandatory Preemptive Skin Testing Policies
This study demonstrates the effectiveness of HK-DADI in correcting widespread mislabeling in China and highlights the potential for implementing protocol-based delabeling initiatives across diverse regions. The high rate of mislabeling underscores the urgent need for reform of PST practices and supports global efforts to combat antimicrobial resistance with protocol-based delabeling initiatives.
Authors
- Philip Hei Li (ORCID: https://orcid.org/0000-0002-9155-9162)
- Xiangling Zhang
- Thomas S. H. Chik
- Feng Xu (ORCID: https://orcid.org/0009-0007-5772-2513)
- Timothy C. M. Li
- Andy Ka Chun Kan (ORCID: https://orcid.org/0000-0002-1943-2562)
- Jinxian Huang (ORCID: https://orcid.org/0000-0001-5073-1205)
- Weihong Shi
- Ning Liu (ORCID: https://orcid.org/0000-0001-7497-5183)
- Juan Meng (ORCID: https://orcid.org/0000-0002-5674-4485)
- Man Yee Chu
Institutions
- Sichuan University (CN)
- Queen Mary Hospital (CN)
- West China Hospital of Sichuan University (CN)
- Prince of Wales Hospital (CN)
- Princess Margaret Hospital (HK)
- University of Hong Kong - Shenzhen Hospital (CN)
- Queen Elizabeth Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- The Journal of Allergy and Clinical Immunology In Practice
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1016/j.jaip.2025.12.004
- Citations
- 1
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.39